BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Prifetrastat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Prifetrastat\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07721402-9082@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20261208
DTEND;VALUE=DATE:20261209
SUMMARY:Prifetrastat: Phase 1 readout est. (NCT07721402)
DESCRIPTION:Prifetrastat\, phase 1.\nStudy: A Study to Learn About How Diff
 erent Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in 
 Healthy Adults\nEstimated primary completion: 8 December 2026. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/prifetrastat#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07721402
URL:https://assetmemo.bio/drug/prifetrastat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07062965-9082@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20270722
DTEND;VALUE=DATE:20270723
SUMMARY:Prifetrastat: Phase 3 readout est. (NCT07062965)
DESCRIPTION:Prifetrastat\, phase 3\, HR+/HER2- Metastatic Breast Cancer.\nS
 tudy: A Study to Learn About the Study Medicine Called PF-07248144 in Comb
 ination With Fulvestrant in People With HR-positive\, HER2-negative Advanc
 ed or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatm
 ent.\nEstimated primary completion: 22 July 2027. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/prifetrastat#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT07062965
URL:https://assetmemo.bio/drug/prifetrastat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07933848-9082@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20280521
DTEND;VALUE=DATE:20280522
SUMMARY:Prifetrastat: Phase 1 readout est. (NCT07933848)
DESCRIPTION:Prifetrastat\, phase 1.\nStudy: A Study to Learn About the Stud
 y Medicine Called Prifetrastat in People With Renal Impairment\nEstimated 
 primary completion: 21 May 2028. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/prifetrastat#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07933848
URL:https://assetmemo.bio/drug/prifetrastat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07340619-9082@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20281118
DTEND;VALUE=DATE:20281119
SUMMARY:Prifetrastat: Phase 2 readout est. (NCT07340619)
DESCRIPTION:Prifetrastat\, phase 2\, HR+/HER2- Metastatic Breast Cancer.\nS
 tudy: Clinical Trial Evaluating the Biological Activity of a New Drug Iden
 tified as Prifetrastat (PF-07248144)\, Combined With Fulvestrant for the T
 reatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negativ
 e (HER2-) Breast Cancer Extended to Other Organs.\nEstimated primary compl
 etion: 18 November 2028. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/prifetrastat#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07340619
URL:https://assetmemo.bio/drug/prifetrastat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04606446-9082@assetmemo.bio
DTSTAMP:20261121T005730Z
DTSTART;VALUE=DATE:20290827
DTEND;VALUE=DATE:20290828
SUMMARY:Prifetrastat: Phase 2 readout est. (NCT04606446)
DESCRIPTION:Prifetrastat\, phase 2\, Non-Small Cell Lung Cancer.\nStudy: St
 udy of PF-07248144 in Advanced or Metastatic Solid Tumors\nEstimated prima
 ry completion: 27 August 2029. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/prifetrastat#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT04606446
URL:https://assetmemo.bio/drug/prifetrastat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
